Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Rael
Comparative Efficacy of Combination Immunotherapy and Targeted Therapy in the Treatment of BRAF-mutant Advanced Melanoma: A Matching-Adjusted Indirect Comparison
Immunotherapy
Oncology
Allergy
Immunology
Additivity of Nebivolol/Valsartan Single-Pill Combinations Versus Other Single-Pill Combinations for Hypertension
Journal of Clinical Hypertension
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Related publications
Cessation of Targeted Therapy After a Complete Response in BRAF-mutant Advanced Melanoma: A Case Series
British Journal of Cancer
Cancer Research
Oncology
Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma
Cancers
Cancer Research
Oncology
Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
Frontiers in Immunology
Allergy
Immunology
Combining Targeted Therapy With Immunotherapy inBRAF-Mutant Melanoma: Promise and Challenges
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Pcn37 - Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Encorafenib/Binimetinib for the Treatment of BRAF-mutant Advanced, Unresectable, or Metastatic Melanoma: Design, Development, and Potential Place in Therapy
OncoTargets and Therapy
Oncology
Pharmacology
Matching Adjusted Indirect Comparison of Sunitinib and Everolimus for the Treatment of Pancreatic Neuroendocrine Tumours (PNETS)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental